Prestige Consumer Healthcare
PBH
#4268
Rank
S$3.51 B
Marketcap
S$73.06
Share price
-0.54%
Change (1 day)
-30.81%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): S$4.94

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is S$4.87. In 2024 the company made an earnings per share (EPS) of S$5.49 an increase over its 2023 EPS that were of S-$2.06.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$4.94-9.96%
2024S$5.49-367.08%
2023S-$2.06-138.33%
2022S$5.3611.7%
2021S$4.8013.6%
2020S$4.23-651.67%
2019S-$0.77-148.78%
2018S$1.57-83.29%
2017S$9.40437.23%
2016S$1.75-34.13%
2015S$2.6652.94%
2014S$1.74-8.11%
2013S$1.89
2011S$1.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.22 192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
S$8.82 81.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.19 88.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.74-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.79-1.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
S$7.85 61.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
S$1.80-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.81-1.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
S-$37.82-877.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
S$1.56-67.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel